erythropoietin
Commercial- Indications
- Anemia in chronic kidney disease
Company intelligence / Profile preview
Drogsan Pharmaceuticals has nearly five decades of experience in R&D, manufacturing, marketing, and sales of pharmaceutical products for both local and global markets. The company emphasizes continuous improvement and innovation with a strong export focus. It holds GMP certification and participates in the TURQUALITY® state-supported branding program as one of Turkey’s leading pharma exporters. No clinical trial results or investigational pipeline are publicly disclosed; the business centers on commercialized generics/brands.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Drogsan Pharmaceuticals.